Tempest Therapeutics, Inc. — Director's Dealing 2021

Jul 7, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Tempest Therapeutics, Inc. (TPST)
CIK: 0001544227
Period of Report: 2021-07-01

Reporting Person: Woiwode Thomas (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-01	Stock Option (Right to Buy)	$11.07	A	6635	Acquired	2031-06-30	Common Stock (6635)	Direct

Footnotes

F1: One-fourth of the shares underlying this option vest on July 1, 2022, and the remaining shares vest in a series of 36 equal monthly installments thereafter, subject to the reporting person's continued service.